BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18405395)

  • 1. A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia.
    Nicolaou P; Georghiou A; Votsi C; Middleton LT; Zamba-Papanicolaou E; Christodoulou K
    BMC Med Genet; 2008 Apr; 9():28. PubMed ID: 18405395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel senataxin mutations in Chinese patients with autosomal recessive cerebellar ataxias by targeted next-generation sequencing.
    Lu C; Zheng YC; Dong Y; Li HF
    BMC Neurol; 2016 Sep; 16(1):179. PubMed ID: 27644330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoprotein.
    Nanetti L; Cavalieri S; Pensato V; Erbetta A; Pareyson D; Panzeri M; Zorzi G; Antozzi C; Moroni I; Gellera C; Brusco A; Mariotti C
    Orphanet J Rare Dis; 2013 Aug; 8():123. PubMed ID: 23941260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Pseudodominant inheritance" of ataxia with ocular apraxia type 2 (AOA2).
    Schöls L; Arning L; Schüle R; Epplen JT; Timmann D
    J Neurol; 2008 Apr; 255(4):495-501. PubMed ID: 18350359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia.
    Bohlega SA; Shinwari JM; Al Sharif LJ; Khalil DS; Alkhairallah TS; Al Tassan NA
    BMC Med Genet; 2011 Feb; 12():27. PubMed ID: 21324166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxia with oculomotor apraxia type 2: a clinical and genetic study of 19 patients.
    Tazir M; Ali-Pacha L; M'Zahem A; Delaunoy JP; Fritsch M; Nouioua S; Benhassine T; Assami S; Grid D; Vallat JM; Hamri A; Koenig M
    J Neurol Sci; 2009 Mar; 278(1-2):77-81. PubMed ID: 19141356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.
    Criscuolo C; Chessa L; Di Giandomenico S; Mancini P; Saccà F; Grieco GS; Piane M; Barbieri F; De Michele G; Banfi S; Pierelli F; Rizzuto N; Santorelli FM; Gallosti L; Filla A; Casali C
    Neurology; 2006 Apr; 66(8):1207-10. PubMed ID: 16636238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage.
    Roda RH; Rinaldi C; Singh R; Schindler AB; Blackstone C
    J Clin Neurosci; 2014 Sep; 21(9):1627-31. PubMed ID: 24814856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.
    Moreira MC; Klur S; Watanabe M; Németh AH; Le Ber I; Moniz JC; Tranchant C; Aubourg P; Tazir M; Schöls L; Pandolfo M; Schulz JB; Pouget J; Calvas P; Shizuka-Ikeda M; Shoji M; Tanaka M; Izatt L; Shaw CE; M'Zahem A; Dunne E; Bomont P; Benhassine T; Bouslam N; Stevanin G; Brice A; Guimarães J; Mendonça P; Barbot C; Coutinho P; Sequeiros J; Dürr A; Warter JM; Koenig M
    Nat Genet; 2004 Mar; 36(3):225-7. PubMed ID: 14770181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.
    Anheim M; Monga B; Fleury M; Charles P; Barbot C; Salih M; Delaunoy JP; Fritsch M; Arning L; Synofzik M; Schöls L; Sequeiros J; Goizet C; Marelli C; Le Ber I; Koht J; Gazulla J; De Bleecker J; Mukhtar M; Drouot N; Ali-Pacha L; Benhassine T; Chbicheb M; M'Zahem A; Hamri A; Chabrol B; Pouget J; Murphy R; Watanabe M; Coutinho P; Tazir M; Durr A; Brice A; Tranchant C; Koenig M
    Brain; 2009 Oct; 132(Pt 10):2688-98. PubMed ID: 19696032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2.
    Bernard V; Minnerop M; Bürk K; Kreuz F; Gillessen-Kaesbach G; Zühlke C
    BMC Med Genet; 2009 Sep; 10():87. PubMed ID: 19744353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous deletion in exon 6 of
    Kinkar JS; Jameel PZ; Kumawat BL; Kalbhor P
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34193451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin.
    Airoldi G; Guidarelli A; Cantoni O; Panzeri C; Vantaggiato C; Bonato S; Grazia D'Angelo M; Falcone S; De Palma C; Tonelli A; Crimella C; Bondioni S; Bresolin N; Clementi E; Bassi MT
    Neurogenetics; 2010 Feb; 11(1):91-100. PubMed ID: 19593598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
    Anheim M; Fleury MC; Franques J; Moreira MC; Delaunoy JP; Stoppa-Lyonnet D; Koenig M; Tranchant C
    Arch Neurol; 2008 Jul; 65(7):958-62. PubMed ID: 18625865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management.
    Anheim M; Fleury M; Monga B; Laugel V; Chaigne D; Rodier G; Ginglinger E; Boulay C; Courtois S; Drouot N; Fritsch M; Delaunoy JP; Stoppa-Lyonnet D; Tranchant C; Koenig M
    Neurogenetics; 2010 Feb; 11(1):1-12. PubMed ID: 19440741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique Ataxia-Oculomotor Apraxia 2 (AOA2) in Israel with Novel Variants, Atypical Late Presentation, and Possible Identification of a Poison Exon.
    Ponger P; Kurolap A; Lerer I; Dagan J; Chai Gadot C; Mory A; Wilnai Y; Oniashvili N; Giladi N; Gurevich T; Meiner V; Lossos A; Baris Feldman H
    J Mol Neurosci; 2022 Aug; 72(8):1715-1723. PubMed ID: 35676594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
    Renaud M; Tranchant C; Koenig M; Anheim M
    Mov Disord; 2020 Dec; 35(12):2139-2149. PubMed ID: 33044027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2.
    Fogel BL; Cho E; Wahnich A; Gao F; Becherel OJ; Wang X; Fike F; Chen L; Criscuolo C; De Michele G; Filla A; Collins A; Hahn AF; Gatti RA; Konopka G; Perlman S; Lavin MF; Geschwind DH; Coppola G
    Hum Mol Genet; 2014 Sep; 23(18):4758-69. PubMed ID: 24760770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant splicing of the senataxin gene in a patient with ataxia with oculomotor apraxia type 2.
    Fogel BL; Lee JY; Perlman S
    Cerebellum; 2009 Dec; 8(4):448-53. PubMed ID: 19727998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents.
    Vantaggiato C; Cantoni O; Guidarelli A; Romaniello R; Citterio A; Arrigoni F; Doneda C; Castelli M; Airoldi G; Bresolin N; Borgatti R; Bassi MT
    Brain Dev; 2014 Sep; 36(8):682-9. PubMed ID: 24183476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.